Lengo Therapeutics Funding & Investors
Lengo Therapeutics a biopharmaceutical company focused on the discovery and development of cancer treatments. Lengo works to identify several mutations in cancers that were not well addressed by existing therapeutics, helping medical practitioners and pharma companies to target driver mutations in oncology.
lengotx.comTotal Amount Raised: $15,000,000
Lengo Therapeutics Funding Rounds
Series A
$15,000,000
Series A Investors
Frazier Management
Funding info provided by Diffbot.